Enza Lonardo Stem Cells & Cancer Group, Molecular Pathology Program Spanish National Cancer Research Center Biography Publications Institution JoVE Articles Enza Lonardo has not added a biography. If you are Enza Lonardo and would like to personalize this page please email our Author Liaison for assistance. Publications The MiR-17-92 Cluster Counteracts Quiescence and Chemoresistance in a Distinct Subpopulation of Pancreatic Cancer Stem Cells Gut. Apr, 2015 | Pubmed ID: 25887381 Stromal Gene Expression Defines Poor-prognosis Subtypes in Colorectal Cancer Nature Genetics. Apr, 2015 | Pubmed ID: 25706628 Intracellular Autofluorescence: a Biomarker for Epithelial Cancer Stem Cells Nature Methods. Nov, 2014 | Pubmed ID: 25262208 Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells PloS One. 2013 | Pubmed ID: 24204632 Cripto Regulates Skeletal Muscle Regeneration and Modulates Satellite Cell Determination by Antagonizing Myostatin Proceedings of the National Academy of Sciences of the United States of America. Nov, 2012 | Pubmed ID: 23129614 Pancreatic Stellate Cells Form a Niche for Cancer Stem Cells and Promote Their Self-renewal and Invasiveness Cell Cycle (Georgetown, Tex.). Apr, 2012 | Pubmed ID: 22421149 Nodal/Activin Signaling Drives Self-renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy Cell Stem Cell. Nov, 2011 | Pubmed ID: 22056140 Pancreatic Cancer Stem Cells: New Insights and Perspectives Journal of Gastroenterology. Aug, 2011 | Pubmed ID: 21698355 A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation, and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease Stem Cells (Dayton, Ohio). Aug, 2010 | Pubmed ID: 20641036 Pancreatic Cancer Stem Cells - Update and Future Perspectives Molecular Oncology. Oct, 2010 | Pubmed ID: 20580623 Lack of Sik1 in Mouse Embryonic Stem Cells Impairs Cardiomyogenesis by Down-regulating the Cyclin-dependent Kinase Inhibitor P57kip2 PloS One. 2010 | Pubmed ID: 20140255 Cripto-1 is Required for Hypoxia to Induce Cardiac Differentiation of Mouse Embryonic Stem Cells The American Journal of Pathology. Nov, 2009 | Pubmed ID: 19834060 G Protein-coupled Receptor APJ and Its Ligand Apelin Act Downstream of Cripto to Specify Embryonic Stem Cells Toward the Cardiac Lineage Through Extracellular Signal-regulated Kinase/p70S6 Kinase Signaling Pathway Circulation Research. Jul, 2009 | Pubmed ID: 19574549 Effects of Indole-3-acetic Acid on Sinorhizobium Meliloti Survival and on Symbiotic Nitrogen Fixation and Stem Dry Weight Production Applied Microbiology and Biotechnology. Jun, 2009 | Pubmed ID: 19343341 Qualitative and Quantitative Proteomic Profiling of Cripto(-/-) Embryonic Stem Cells by Means of Accurate Mass LC-MS Analysis Journal of Proteome Research. Feb, 2009 | Pubmed ID: 19152270 Introduction of a Novel Pathway for IAA Biosynthesis to Rhizobia Alters Vetch Root Nodule Development Archives of Microbiology. Jul, 2008 | Pubmed ID: 18415080 Cripto Promotes A-P Axis Specification Independently of Its Stimulatory Effect on Nodal Autoinduction The Journal of Cell Biology. Feb, 2008 | Pubmed ID: 18268105 Studere i bugspytkirtlen Kræft stamceller Karakteristik for udvikling af nye behandlingsstrategier Enza Lonardo1,2, Michele Cioffi1, Patricia Sancho1,3, Shanthini Crusz3, Christopher Heeschen1,3 1Stem Cells & Cancer Group, Molecular Pathology Program, Spanish National Cancer Research Center, 2Institute for Research in Biomedicine (IRB Barcelona), 3Center for Stem Cells in Cancer & Ageing, Barts Cancer Institute, Queen Mary University of London Medicina
Studere i bugspytkirtlen Kræft stamceller Karakteristik for udvikling af nye behandlingsstrategier Enza Lonardo1,2, Michele Cioffi1, Patricia Sancho1,3, Shanthini Crusz3, Christopher Heeschen1,3 1Stem Cells & Cancer Group, Molecular Pathology Program, Spanish National Cancer Research Center, 2Institute for Research in Biomedicine (IRB Barcelona), 3Center for Stem Cells in Cancer & Ageing, Barts Cancer Institute, Queen Mary University of London Medicina